Could a common pill shield kidneys from hospital scans?
NCT ID NCT07291375
Summary
This early study is testing if a very low dose of a common blood pressure medication (amlodipine) can help protect the kidneys of diabetic patients in the intensive care unit. The goal is to prevent kidney damage that can sometimes be caused by the dye used in CT scans and other imaging tests. Researchers will give the pill to a small group of patients and closely monitor their kidney function for two days after their scan.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONTRAST-INDUCED NEPHROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.